SIGNATUREFD, LLC - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 49 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2019. The put-call ratio across all filers is 8.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2023$47,129
-22.3%
54,1770.0%0.00%
-50.0%
Q2 2023$60,678
+7.7%
54,1770.0%0.00%0.0%
Q1 2023$56,344
-7.1%
54,1770.0%0.00%0.0%
Q4 2022$60,678
-0.5%
54,1770.0%0.00%0.0%
Q3 2022$61,000
-23.8%
54,1770.0%0.00%
-33.3%
Q2 2022$80,000
-35.5%
54,1770.0%0.00%
-25.0%
Q1 2022$124,000
-16.8%
54,1770.0%0.00%
-20.0%
Q4 2021$149,000
-54.4%
54,177
-0.5%
0.01%
-54.5%
Q3 2021$327,000
+23.9%
54,462
+0.5%
0.01%0.0%
Q2 2021$264,000
+97.0%
54,1770.0%0.01%
+83.3%
Q1 2021$134,000
-9.5%
54,1770.0%0.01%
-14.3%
Q4 2020$148,000
-19.6%
54,177
-54.7%
0.01%
-30.0%
Q3 2020$184,000
-19.3%
119,701
-1.4%
0.01%
-28.6%
Q2 2020$228,000
+10.1%
121,351
-0.5%
0.01%
-22.2%
Q1 2020$207,000
+22.5%
121,986
+109.1%
0.02%
+50.0%
Q4 2019$169,000
+45.7%
58,326
-68.3%
0.01%
+20.0%
Q3 2019$116,000
-35.2%
183,9860.0%0.01%
-33.3%
Q2 2019$179,000
-29.5%
183,9860.0%0.02%
-31.8%
Q1 2019$254,000
+28.9%
183,9860.0%0.02%
+22.2%
Q4 2018$197,000
-45.1%
183,986
+215.4%
0.02%
-50.0%
Q3 2018$359,000
+385.1%
58,326
+743.5%
0.04%
+350.0%
Q2 2018$74,0006,9150.01%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q4 2019
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,467,500$14,805,0007.67%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$7,898,0002.79%
AJU IB Investment Co., Ltd. 293,555$1,761,0001.14%
RTW INVESTMENTS, LP 4,206,765$25,241,0000.38%
EAM Investors, LLC 247,561$1,485,0000.25%
Carmignac Gestion 2,475,652$14,854,0000.18%
Curi Wealth Management, LLC 25,000$150,0000.07%
CAXTON ASSOCIATES LP 66,569$399,0000.04%
Newman Dignan & Sheerar, Inc. 21,523$129,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,900,0000.04%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders